Bankrupt 23andMe to be bought by pharmaceutical company Regeneron for $256 million
- Posted on May 19, 2025
- By Usa Today
- 3 Views
Bankrupt 23andMe to be bought by pharmaceutical company Regeneron for $256 million
Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.
